Related Experiment Video

Updated: Nov 19, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.5K

Current Perspectives of convalescent plasma therapy in COVID-19

Kamal Kant Sahu1, Ajay Kumar Mishra2, Manish Raturi3

  • 1Department of Medicine Saint Vincent Hospital Worcester, MA. kamalkant.sahu@stvincenthospital.com.

Acta Bio-Medica : Atenei Parmensis
|February 2, 2021
PubMed

Insights

Convalescent Plasma therapy is emerging as a potential treatment for critically ill COVID-19 patients. This discussion explores its therapeutic application, donor challenges, and global experiences.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Transfusion Medicine

Background:

  • The COVID-19 pandemic presents a significant global health challenge with a high burden of severe cases.
  • Limited definitive treatment options exist for COVID-19 pneumonia, driving research into alternative therapies.
  • Convalescent Plasma therapy has gained attention as a potential treatment for severe COVID-19.

Purpose of the Study:

  • To discuss the therapeutic potential of Convalescent Plasma for COVID-19.
  • To highlight challenges associated with identifying suitable plasma donors.
  • To review transfusion medicine responsibilities and current global experiences with this therapy.

Main Methods:

  • Review of preliminary reports and ongoing research on Convalescent Plasma therapy.
  • Discussion of donor selection criteria and safety protocols.
  • Analysis of global case studies and outcomes.

Main Results:

  • Preliminary findings suggest positive outcomes with Convalescent Plasma in some critically ill COVID-19 patients.
  • Challenges include donor availability, antibody titer standardization, and optimal timing of transfusion.
  • Transfusion medicine plays a crucial role in ensuring safe and effective plasma administration.

Conclusions:

  • Convalescent Plasma therapy shows promise as a supportive treatment for severe COVID-19.
  • Further research and standardized protocols are necessary to optimize its use.
  • Addressing donor recruitment and logistical challenges is vital for wider implementation.

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K
A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood06:10

A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood

Published on: August 15, 2025

934

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
581
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
114
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
262
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
139
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
433
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
106